Inclusion Criteria:  • Participant must have received AVR-RD-04 (also known as CTNS-RD-04) in a preceding study  Exclusion Criteria:  • Participant is currently enrolled in an AVRO-RD-04 treatment study. Participants who have either completed, withdrawn, or prematurely discontinued participation for any reason at any time after receiving AVR RD-04 are eligible for AVRO RD 04 LTF01 study participation.